Mechanistically, CG-806 profoundly suppresses FLT3, BTK, and AURK activation simultaneously and results in impressive cytotoxicity in these AML cells, particularly against FLT3-WT AML cells which demonstrated abnormally high expression of aurora kinase. The gene discussed is FLT3; the disease is acute myeloid leukemia.